ArticleGut and liver2011

Infliximab therapy impacts the peripheral immune system of immunomodulator and corticosteroid naïve patients with Crohn's disease.

Kyoichi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.